CardiAQ Valve Technologies

About:

CardiAQ Valve Technologies develops innovative approaches to heart valve replacement, focused on transcatheter mitral valve implantation.

Website: http://www.cardiaq.com

Twitter/X: edwardslifesci

Top Investors: OrbiMed, Versant Ventures, Broadview Ventures, Advent Life Sciences, Invus Opportunities

Description:

CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).

Total Funding Amount:

$45.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2007-01-01

Contact Email:

investor_relations(AT)edwards.com

Founders:

Arshad Quadri, Brent Ratz, Zoran Maricevic

Number of Employees:

5001-10000

Last Funding Date:

2012-11-29

IPO Status:

Private

Industries: